Approval · Notice of Compliance 7379 · 2005
FASTURTEC: Notice of Compliance 7379
Issued September 15, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7379
- Date
- September 15, 2005
- Company
- Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentation
- Therapeutic class
- Uricolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FASTURTEC | 02271397 | Cancelled Pre Market |
Medicinal ingredients
- RASBURICASE 7.5 MG per VIAL